سعر سيفيديم 250 مجم فيال 2026

Cefidime 250mg vial: Ceftazidime (Eipico).

• Parenteral third-generation cephalosporin with antipseudomonal activity for susceptible lower respiratory, skin/skin-structure, UTI, septicemia, bone/joint, gynecologic, intra-abdominal, and CNS infections including meningitis as labeled (US ceftazidime for injection labeling).Population: Adults / as labeledDailyMed (U.S. National Library of Medicine)

• Contraindicated in patients with hypersensitivity to ceftazidime or the cephalosporin group (US label).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Cross-hypersensitivity with beta-lactams; CDAD; elevated levels in renal insufficiency can cause seizures/encephalopathy — adjust dose; monitor for resistance development during therapy (US label).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Aminoglycosides / potent diureticsNephrotoxicity reported with cephalosporins plus aminoglycosides or potent diuretics; monitor renal function (US label).DailyMed (U.S. National Library of Medicine)
• ChloramphenicolIn vitro antagonism with beta-lactams including ceftazidime; avoid combination when bactericidal activity desired (US label).DailyMed (U.S. National Library of Medicine)

• Animal studies without evidence of fetal harm at high multiples of human dose; no adequate well-controlled human studies; use only if clearly needed (US label).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Excreted in human milk in low concentrations; use caution (US label).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Ceftazidime: Parenteral third-generation cephalosporin inhibiting cell-wall synthesis; notable activity against Pseudomonas aeruginosa.